Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 841-852 of 4,306
Behavioral study icon
Not recruitingISRCTN01816159

Quality of Life following Adherence Therapy for People Disabled by Schizophrenia and their Carers

This study is looking at whether Patients will receive 8 sessions of either adherence therapy or health education delivered by a trained therapist in each of the five sites can help people with Schizophrenia or Mental and Behavioural Disorders. Participants receive a study treatment and complete follow-up visits and assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom, Germany, Italy, ...
Sponsor
King's College London (UK)
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN24327446

Effect of mindfulness based intervention in cognitive functions and psychological well-being applied as an early intervention for schizophrenia

This study is not recruiting in Chile. It is testing effect of mindfulness based intervention in cognitive functions and psychological well-being applied as an early intervention for schizophrenia.

In Chile
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
Chile
Sponsor
Universidad Austral de Chile
Condition
Schizophrenia
Behavioral study icon
Not recruitingISRCTN44277627

The effectiveness of cognitive remediation therapy (CRT) for people with schizophrenia

This study is looking at whether 1 can help people with Mental and behavioural disorders: Schizophrenia and other psychoses, Mental and Behavioural Disorders, or Schizophrenia. Participants take part in 1 and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
NHS R&D Regional Programme Register - Department of Health (UK)
Condition
Schizophrenia
Other study type icon
Not recruitingISRCTN84658943

To tweet or not to tweet about schizophrenia

This study is looking at whether Intervention can help people with Schizophrenia or Mental and Behavioural Disorders. Participants take part in Intervention and complete follow-up assessments.

In United Kingdom
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaOther
Countries
United Kingdom
Sponsor
Nottinghamshire Healthcare NHS Trust (UK)
Condition
Schizophrenia
Behavioral study icon
CompletedNCT06880328

18F-Dihydroxyphenylalanine (DOPA) Positron Emission Tomography (PET) Study to Explore Dopamine Synthesis Capacity in the Whole Striatum After 2 Weeks of Treatment With Ralmitaront or Placebo in people with Schizophrenia

This study is completed in the United States. It focuses on schizophrenia.

Multiple locations, including Glendale
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 50 Years
Countries
United States
Sponsor
Hoffmann-La Roche
Condition
Schizophrenia
Drug study icon
CompletedNCT01098110

Asenapine Compared to Placebo for schizophrenia

This study is completed. It is testing asenapine Compared to Placebo for schizophrenia.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 20 Years to 64 Years
Countries
Sponsor
Organon and Co
Condition
Schizophrenia
Behavioral study icon
CompletedNCT05486312

7-week Study With CT-155 in People With Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Culver City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 64 Years
Countries
United States
Sponsor
Click Therapeutics, Inc.
Condition
Schizophrenia
Other study type icon
TerminatedNCT04742413

A 12-Month Observational Prospective Cohort Study to Analyze Cardiometabolic Profile Changes to Switch to Lurasidone in people with Schizophrenia. RESPECT Study.

This study was terminated in Spain. It focuses on schizophrenia.

Multiple locations, including Málaga
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.Over 18 Years
Countries
Spain
Sponsor
Angelini Farmacéutica
Condition
Schizophrenia
Drug study icon
CompletedNCT03465787

Lurasidone HCL for schizophrenia

This study is completed in South Korea. It is testing Lurasidone HCL for schizophrenia.

In Seoul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 19 Years to 75 Years
Countries
South Korea
Sponsor
Bukwang Pharmaceutical
Condition
Schizophrenia
Other study type icon
UnknownNCT06515522

A Biological Signature for the Early Differential Diagnosis of Psychosis

This summary needs review. Please check the official study record and contact the research team for details.

Location not clearly listed
Why is this study shown?

This study is directly about Schizophrenia.

Schizophrenia, Depression, ...ObservationalFrom 18 Years to 65 Years
Countries
Sponsor
IRCCS San Raffaele
Condition
Schizophrenia, Depression, ...
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.